- Home
- RNLX
RNLX
Renalytix plc
as 07-26-2024 4:00pm EST
Renalytix PLC is a developer of artificial intelligence-enabled clinical in vitro diagnostic solutions for kidney disease, one of the common and costly chronic medical conditions globally. The company's product is KidneyIntelX which is being designed to make improvements in kidney disease prognosis, transplant management, clinical care, patient stratification for drug clinical trials, and drug target discovery.
| Founded: | 2018 | Country: | United States |
| Employees: | N/A | City: | LONDON |
| Market Cap: | 25.4M | IPO Year: | 2020 |
| Target Price: | $3.00 | AVG Volume (30 days): | 5.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.78 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.22 - $3.14 | Next Earning Date: | 05-15-2024 |
| Revenue: | $2,221,000 | Revenue Growth: | -40.23% |
| Revenue Growth (this year): | 48.4% | Revenue Growth (next year): | 104.00% |
Latest Renalytix plc News
RNLX Breaking Stock News: Dive into RNLX Ticker-Specific Updates for Smart Investing
GlobeNewswire
16 days ago
Renalytix and Steno Diabetes Center Announce Precision Medicine Collaboration Marking First Expansion for KidneyIntelX Platform Beyond US
MT Newswires
a month ago
Renalytix Requests Hearing With Nasdaq to Maintain Listing
GlobeNewswire
a month ago
Renalytix Submits Hearing Request to Nasdaq Hearings Panel in Regard to Staff Delisting Determination
MT Newswires
a month ago
Renalytix Secures Medicare's Final Local Coverage Determination for Kidney Disease Test
GlobeNewswire
a month ago
Medicare Issues Final Coverage Determination for kidneyintelX.dkd
The Telegraph
2 months ago
Italian energy company targets Britain for fleet of 20 mini-nukes
Motley Fool
2 months ago
4 Reasons to Buy Invesco QQQ Trust Like There's No Tomorrow
AFP
2 months ago
Seoul resumes loudspeaker propaganda against North
Compare RNLX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "RNLX Renalytix plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.